Michelle Burris

Director, ACHIEVE LIFE SCIENCES, INC.

Companies

Adaptive BiotechnologiesBoard member Jun 26, 2019 to now¹
CHINOOK THERAPEUTICS, INC.Board member Oct 7, 2020 to Aug 11, 2023²
Opexa TherapeuticsBoard member Sep 21, 2017 to Mar 16, 2023³
HTG MOLECULAR DIAGNOSTICS, INCBoard member Aug 17, 2018 to Sep 15, 2022⁴
ACHIEVE LIFE SCIENCES, INC.Chief financial officer Jan 4, 2011 to May 10, 2012⁵
ACHIEVE LIFE SCIENCES, INC.Board member May 15, 2006 to Jun 9, 2010⁶

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jun 25, 2026Sold 52,084 shares at $20.18 of Adaptive Biotechnologies⁷
Jun 25, 2026Exercised options 52,084 shares at $7.80 of Adaptive Biotechnologies⁷
Mar 11, 2026Sold 15,394 shares at $13.91 of Adaptive Biotechnologies⁹
Mar 4, 2026Granted 15,625 shares of Adaptive Biotechnologies¹⁰
Mar 3, 2026Sold 48,044 shares at $15.30 of Adaptive Biotechnologies¹¹
Mar 3, 2026Exercised options 48,044 shares at $3.99 of Adaptive Biotechnologies¹¹
Mar 13, 2025Sold 36,291 shares at $7.19 of Adaptive Biotechnologies¹²
Mar 6, 2025Sold 15,664 shares at $7.94 of Adaptive Biotechnologies¹³
Mar 4, 2025Granted 15,394 shares of Adaptive Biotechnologies¹³
Mar 4, 2024Granted 31,328 shares of Adaptive Biotechnologies¹⁴
Aug 11, 2023Returned to company 3,300 shares of CHINOOK THERAPEUTICS, INC.⁸
May 26, 2023Exercised options 3,300 shares of CHINOOK THERAPEUTICS, INC.¹⁵
Mar 27, 2023Sold 2,341 shares at $8.49 of Adaptive Biotechnologies¹⁶
Mar 6, 2023Granted 14,775 shares of Adaptive Biotechnologies¹⁷
Jan 26, 2022Granted 6,689 shares of Adaptive Biotechnologies¹⁸

The numbers on this page point here. Each one links to the record it came from.